Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Giermakowska

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
AIDS (London, England)|January 11, 2000
Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Clinical and Experimental Immunology|June 26, 2001
Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvantR B Moss, E Webb, W K Giermakowska, et al.
AIDS Research and Human Retroviruses|July 22, 1998
A primer on HIV type 1-specific immune function and REMUNER B Moss, W K Giermakowska, J R Savary, et al.
Journal of Human Virology|April 25, 2000
CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE)R B Moss, W K Giermakowska, J P Diveley, et al.
Clinical and Experimental Immunology|May 3, 2002
Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccinationR B Moss, M R Wallace, R T Steigbigel, et al.
Immunology|April 1, 1993
Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burdenR J Trauger, W K Giermakowska, F Ferre, et al.
The Journal of Infectious Diseases|August 7, 1999
Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogenR B Moss, M R Wallace, W K Giermakowska, et al.
Journal of Human Virology|April 9, 1999
Tumor necrosis factor alpha and human immunodeficiency virus-specific functional immune responses after immunization with Gp120-depleted, inactivated HIV-1 in incomplete Freund's adjuvant (REMUNE) in HIV-1-seropositive subjectsR B Moss, L Li, W K Giermakowska, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1997
Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infectionR B Moss, R J Trauger, W K Giermakowska, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
AIDS (London, England)|January 11, 2000
Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Clinical and Experimental Immunology|June 26, 2001
Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvantR B Moss, E Webb, W K Giermakowska, et al.
AIDS Research and Human Retroviruses|July 22, 1998
A primer on HIV type 1-specific immune function and REMUNER B Moss, W K Giermakowska, J R Savary, et al.
Journal of Human Virology|April 25, 2000
CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE)R B Moss, W K Giermakowska, J P Diveley, et al.
Clinical and Experimental Immunology|May 3, 2002
Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccinationR B Moss, M R Wallace, R T Steigbigel, et al.
Immunology|April 1, 1993
Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burdenR J Trauger, W K Giermakowska, F Ferre, et al.
The Journal of Infectious Diseases|August 7, 1999
Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogenR B Moss, M R Wallace, W K Giermakowska, et al.
Journal of Human Virology|April 9, 1999
Tumor necrosis factor alpha and human immunodeficiency virus-specific functional immune responses after immunization with Gp120-depleted, inactivated HIV-1 in incomplete Freund's adjuvant (REMUNE) in HIV-1-seropositive subjectsR B Moss, L Li, W K Giermakowska, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1997
Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infectionR B Moss, R J Trauger, W K Giermakowska, et al.
Pageof 1